LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 7.66 | 770.25 | 1021 | 1090 | 0.9367 | 0.7552 | MN20160304_L02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 7.66 | 770.25 | 1108 | 1090 | 1.0165 | 1.0665 | MN20160304_L02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 10.06 | 770.25 | 1121 | 1218 | 0.9200 | 0.7632 | MN20160304_L02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 10.06 | 770.25 | 1204 | 1218 | 0.9881 | 0.9641 | MN20160304_L02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 12.28 | 770.25 | 1308 | 1358 | 0.9631 | 0.9102 | MN20160304_L02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 12.28 | 770.25 | 1352 | 1358 | 0.9955 | 0.9890 | MN20160304_L02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 14.50 | 770.25 | 1464 | 1497 | 0.9778 | 0.9537 | MN20160304_L02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 14.50 | 770.25 | 1468 | 1497 | 0.9805 | 0.9593 | MN20160304_L02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 16.73 | 770.25 | 1623 | 1664 | 0.9751 | 0.9551 | MN20160304_L02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 16.73 | 770.25 | 1622 | 1664 | 0.9745 | 0.9540 | MN20160304_L02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 18.95 | 770.25 | 1726 | 1832 | 0.9419 | 0.9065 | MN20160304_L02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 18.95 | 770.25 | 1792 | 1832 | 0.9779 | 0.9646 | MN20160304_L02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 21.17 | 770.25 | 1903 | 2008 | 0.9475 | 0.9235 | MN20160304_L02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 21.17 | 770.25 | 1975 | 2008 | 0.9834 | 0.9759 | MN20160304_L02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 23.39 | 770.25 | 2137 | 2244 | 0.9521 | 0.9374 | MN20160304_L02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 23.39 | 770.25 | 2233 | 2244 | 0.9949 | 0.9934 | MN20160304_L02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 25.62 | 770.25 | 2431 | 2514 | 0.9667 | 0.9607 | MN20160304_L02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 25.62 | 770.25 | 2530 | 2514 | 1.0060 | 1.0070 | MN20160304_L02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 27.84 | 770.25 | 2655 | 2833 | 0.9369 | 0.9318 | MN20160304_L02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 27.84 | 770.25 | 2785 | 2833 | 0.9828 | 0.9816 | MN20160304_L02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 30.06 | 770.25 | 2925 | 3106 | 0.9417 | 0.9412 | MN20160304_L02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 30.06 | 770.25 | 3045 | 3106 | 0.9803 | 0.9803 | MN20160304_L02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 32.28 | 770.25 | 3181 | 3392 | 0.9376 | 0.9406 | MN20160304_L02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 32.28 | 770.25 | 3382 | 3392 | 0.9968 | 0.9970 | MN20160304_L02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 34.50 | 770.25 | 3452 | 3712 | 0.9300 | 0.9370 | MN20160304_L02 | E03 |